Rituximab, Pentostatin, Cyclophosphamide, and Lenalidomide in Treating Patients With Previously Untreated B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Clinical trial NCT00602836 · COMPLETED
Trial details
- NCT number
- NCT00602836
- Sponsor
- Mayo Clinic
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-02-01
- Primary completion
- 2010-12-01
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.